Literature DB >> 7553713

Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response.

A M McAinsh1, M A Turner, D O'Hare, R Nithythyananthan, D G Johnston, D J O'Gorman, D J Sheridan.   

Abstract

OBJECTIVE: The aim was to investigate whether impaired coronary flow reserve associated with cardiac hypertrophy could significantly limit the flow debt repayment following short periods of coronary occlusion and exacerbate or prolong episodes of myocardial ischaemia.
METHODS: Left ventricular hypertrophy was induced in guinea pigs by aortic constriction and the hearts were isolated six weeks later for Langendorff perfusion. Sham operated animals served as controls. The reactive hyperaemic response was studied following various lengths of occlusion of flow and the extent of aerobic and anaerobic metabolism was assessed in each group.
RESULTS: Heart weight/body weight ratio was increased by approximately 25% (P < 0.001) with aortic constriction. The reactive hyperaemic flow response in isolated hearts was impaired by hypertrophy in both magnitude (P < 0.05) and duration. The repayment of flow debt was also significantly reduced, suggesting an inadequate recovery of the myocardium following the occlusion. The total amount of O2 consumed by the heart throughout the duration of hyperaemia was less in hypertrophy than in sham operated controls, suggesting a decrease in aerobic metabolism. Total lactate discharge expressed as a ratio of O2 consumed, which provides an estimation of the degree of anaerobic in relation to aerobic metabolism, was greater in hypertrophy than in sham operated controls.
CONCLUSIONS: The hypertrophied heart is more vulnerable to brief periods of ischaemia because of an impaired reactive hyperaemic response which results in delayed metabolic recovery. These abnormalities may contribute to the increased morbidity associated with cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553713

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

3.  Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  A M McAinsh; M Geyer; J Fandrey; J C Rüegg; R J Wiesner
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

4.  Early Left and Right Ventricular Response to Aortic Valve Replacement.

Authors:  Andra E Duncan; Sheryar Sarwar; Babak Kateby Kashy; Abraham Sonny; Shiva Sale; Andrej Alfirevic; Dongsheng Yang; James D Thomas; Marc Gillinov; Daniel I Sessler
Journal:  Anesth Analg       Date:  2017-02       Impact factor: 5.108

5.  Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results from a multicentre randomized controlled trial: the SCAT trial.

Authors:  Chris A Rogers; Radek Capoun; Lauren J Scott; Jodi Taylor; Anil Jain; Gianni D Angelini; Pradeep Narayan; M-Saadeh Suleiman; Kunal Sarkar; Raimondo Ascione
Journal:  Eur J Cardiothorac Surg       Date:  2017-08-01       Impact factor: 4.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.